AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

Spinal cord stimulation can reduce pain and restore nerve function among patients with diabetic peripheral neuropathy.

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

AI-assisted insulin titration was noninferior to endocrinologists in managing glycemic control among patients with type 2 diabetes.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

A new White House report says today’s children are the sickest generation in U.S. history when it comes to chronic disease.

Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.

The prices charged at the US launch of targeted cancer therapies have increased well above the rate of inflation every year since 2012.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.